Skip to main content
. 2021 Feb 9;9:e10910. doi: 10.7717/peerj.10910

Table 2. Comparison of pre-existing antibody titers between case and control groups.

Antibody titers Case group (Median (min–max)) Control group (Median (min–max)) p
Measles Ig G titers 9,632.50 (263.60–453,221.00) 6,919.75 (201.60–38,133.00) 0.207
Rubella Ig G titers 95.10 (1.30–300.90) 159.30 (17.80–1,833.40) 0.003
Mumps Ig G titers 1,194.00 (291.40–9,445.30) 986.90 (62.20–4,177.30) 0.251
Pneumococcus Ig G titers 0.79 (0.16–9.53) 2.30 (0.08–10.03) 0.002
DiphtheriaIg G titers 0.23 (0.01–1.38) 0.19 (0.03–1.77) 0.895
B. PertussisIg G titers 20.50 (4.50–511.20) 78.35 (1.70–693.50) <0.0001
TetanusIg G titers 1.20 (0.00–9.70) 0.55 (0.00–24.30) 0.489
Varicella Ig G titers 2.95 (0.66–6.28) 2.92 (0.47–5.77) 0.813
H. influenza BIg G titers 68.40 (5.00–1,522.60) 51.55 (7.00–407.50) 0.055

Notes:

min: minimum; max: maximum.

The parameters that were statistically significant in the comparison of the groups were indicated with bold.